Command Palette

Search for a command to run...

Clinical Trials · NCT01750346

Acetyl Hexapeptide-8 for Blepharospasm

TerminatedPhase 2Argireline (Prohibited)
Phase
Phase 2
Recruitment status
Terminated
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Enrollment
8
Start date
Nov 2012
Locations
1 site, United States
Primary endpoint
The Jankovic Blepharospasm Rating Scale at 2 Month
View Argireline compound reference